Analyst Ratings for Neurocrine Biosciences
Portfolio Pulse from Benzinga Insights
Over the past 3 months, 16 analysts have published their opinion on Neurocrine Biosciences (NASDAQ:NBIX) stock. The company has an average price target of $125.25 with a high of $154.00 and a low of $96.00. This average price target has increased by 1.9% over the past month.
August 21, 2023 | 1:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Neurocrine Biosciences has received positive analyst ratings over the past 3 months, with an average price target of $125.25.
The positive analyst ratings and the increase in the average price target over the past month indicate a bullish sentiment towards Neurocrine Biosciences. This could potentially lead to an increase in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100